CANCER IMMUNOTHERAPY
Illustration showing immunomodulators that latch onto the PD-L1 cancer cells and the PD-1 immune cells to block the liaison PD-L1 PD-1 which dampens the immune response to the tumor. When the immune cell recognizes the cancer cell, it can control it (1). But the PD-L1 receptors on the surface of the cancer cell, related to the PD-1 receptors of the immune cells slow down the immune response (2). The anti-PD-L1 and anti-PD-1 immunomodulators latch onto the corresponding receptors and block the liaison between these two receptors (3), blocking the dampening of the immune response.
Size: 4961px × 3969px
Location: France
Photo credit: © JACOPIN / BSIP / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: ab, anatomical, anatomy, antibodies, antibody, art, artwork, biology, cancer, cancerous, cancers, cell, cells, cellular, cytology, drawing, drawings, drug, drugs, human, humans, illustration, illustrations, immune, immunologic, immunological, immunology, malignant, medical, medication, medications, medicinal, medicine, medicines, modifier, modifiers, neoplasia, neoplasm, neoplasms, pharmaceutical, pharmaceuticals, reaction, reactions, response, responses, scheme, schemes, system, therapeutic, therapeutical, treat, treatment, treatments, tumor, tumors, tumour, tumours, work
